I am a
Home I AM A Search Login

Papers of the Week

2022 Jan 10

Neurol Sci

Patient-reported outcomes of migraine treatment with erenumab: results from a national patient survey.


Dapkutė A, Vainauskienė J, Ryliškienė K
Neurol Sci. 2022 Jan 10.
PMID: 35006445.


Despite development of new therapies, migraine remains an undertreated illness. It is important to understand patients' preferences and perceptions of using a certain therapy. We present data from a nationwide Lithuanian survey of patients' experience using erenumab for the treatment of high frequency episodic and chronic migraine.